Featured Image
Why is it important?
The trial design of KEYNOTE-048 trial is very complicated and should be interpreted with caution.
Read the Original
This page is a summary of: New first-line treatment for recurrent or metastatic squamous cell carcinoma of head and neck: does one size fit all?, Therapeutic Radiology and Oncology, June 2020, AME Publishing Company,
DOI: 10.21037/tro.2020.03.02.
You can read the full text:
Contributors
The following have contributed to this page
